CEO of Novo Nordisk to step down

What's new in pharma

May 16, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

LUDOVIC MARIN/POOL/AFP via Getty Images STAT+ | Lars Fruergaard Jørgensen, CEO of Novo Nordisk, to step down as company seeks a turnaround Jørgensen oversaw Novo's explosive growth with the success of Wegovy and Ozempic, but the company has struggled in the past year. By Andrew Joseph FDA clears first blood test for diagnosing Alzheimer's The first Alzheimer's blood test from Fujirebio Diagnostics, now approved by FDA, could help patients with the disease get treatment faster. By Elaine Chen and Adam Feuerstein HHS to stop recommending routine Covid shots for children, pregnant people, RFK Jr. ally says A change in recommendations for vaccination of children and pregnant people would counter advice from the Advisory Committee on Immunization Practices. By Isabella Cueto Adobe STAT+ | Opinion: The FDA is embracing AI boldly. Now it must show what responsible innovation looks like As the FDA embraces AI, it must fiercely protect the autonomy and integrity of its reviewers. By Jennifer Goldsack STAT+ | UnitedHealth's Optum working on Medicare risk scoring system that would use AI UnitedHealth and Optum have a significant interest in helping to build a new coding system, as the firm generates big profits from Medicare Advantage. By Bob Herman Opinion: What's missing from the WHO Pandemic Treaty The WHO Pandemic Treaty reflects a global health system still reliant on charity and unrealistic optimism. By Stephanie Psaki and Ashish K. Jha

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser